Alexander Monto

2.5k total citations
62 papers, 1.8k citations indexed

About

Alexander Monto is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Alexander Monto has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hepatology, 45 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Alexander Monto's work include Hepatitis C virus research (41 papers), Liver Disease Diagnosis and Treatment (36 papers) and Hepatitis B Virus Studies (23 papers). Alexander Monto is often cited by papers focused on Hepatitis C virus research (41 papers), Liver Disease Diagnosis and Treatment (36 papers) and Hepatitis B Virus Studies (23 papers). Alexander Monto collaborates with scholars based in United States, France and Hong Kong. Alexander Monto's co-authors include Teresa L. Wright, Jessica J. Watson, Alan Bostrom, Carlos U. Corvera, Judy Yee, John G. McHutchison, Raymond T. Chung, Phyllis C. Tien, Paul J. Pockros and Stephen Pianko and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Alexander Monto

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Monto United States 22 1.4k 1.3k 130 129 127 62 1.8k
Wendy Cheng Australia 23 1.1k 0.8× 1.0k 0.8× 62 0.5× 253 2.0× 92 0.7× 67 1.6k
Wolf Peter Hofmann Germany 24 1.8k 1.3× 1.7k 1.3× 39 0.3× 268 2.1× 129 1.0× 72 2.3k
Fabio Conti Italy 21 1.3k 0.9× 1.3k 1.0× 83 0.6× 69 0.5× 183 1.4× 98 1.9k
Chung‐Feng Huang Taiwan 28 2.3k 1.6× 2.3k 1.7× 141 1.1× 171 1.3× 128 1.0× 204 3.2k
Rune Wejstål Sweden 23 1.9k 1.3× 1.8k 1.3× 100 0.8× 113 0.9× 51 0.4× 67 2.1k
Zoe Mariñó Spain 21 2.1k 1.5× 1.9k 1.5× 53 0.4× 155 1.2× 160 1.3× 90 2.5k
J. Moussalli France 24 2.3k 1.7× 2.3k 1.8× 92 0.7× 132 1.0× 105 0.8× 56 2.7k
Vijayaprakash Suppiah Australia 17 1.6k 1.1× 1.3k 1.0× 93 0.7× 133 1.0× 39 0.3× 49 2.2k
Thomas Lang Germany 18 685 0.5× 737 0.6× 135 1.0× 42 0.3× 220 1.7× 42 1.5k
Ching‐Sheng Hsu Taiwan 24 1.1k 0.8× 1.1k 0.9× 69 0.5× 67 0.5× 248 2.0× 70 1.8k

Countries citing papers authored by Alexander Monto

Since Specialization
Citations

This map shows the geographic impact of Alexander Monto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Monto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Monto more than expected).

Fields of papers citing papers by Alexander Monto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Monto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Monto. The network helps show where Alexander Monto may publish in the future.

Co-authorship network of co-authors of Alexander Monto

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Monto. A scholar is included among the top collaborators of Alexander Monto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Monto. Alexander Monto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryan, James C., Eréne C. Niemi, Joshua D. Grab, et al.. (2024). Hepatocellular carcinoma after direct‐acting antivirals for hepatitis C is associated with KIR‐HLA types predicting weak NK cell‐mediated immunity. European Journal of Immunology. 54(8). e2350678–e2350678. 1 indexed citations
2.
Wong, Robert J., Derek D. Satre, Alexander Monto, et al.. (2023). Telehepatology Use and Satisfaction Among Vulnerable Cirrhosis Patients Across Three Healthcare Systems in the Coronavirus Disease Pandemic Era. SHILAP Revista de lepidopterología. 3(2). 201–209.
3.
Parikh, Rushi V., Anna E. Barón, Gary K. Grunwald, et al.. (2023). Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Journal of the American Heart Association. 12(4). e028082–e028082. 4 indexed citations
4.
Wong, Robert J., Michael J. Ostacher, Wei Zhang, et al.. (2023). Alcohol Use Patterns During and After the COVID-19 Pandemic Among Veterans in the United States. The American Journal of Medicine. 137(3). 236–239.e2. 9 indexed citations
5.
Sun, Bing, et al.. (2020). Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms. The Journal of Infectious Diseases. 222(3). 396–406. 12 indexed citations
6.
Fuchs, Michael, Alexander Monto, Norbert Bräu, et al.. (2019). Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders. Journal of Medical Virology. 92(12). 3459–3464. 1 indexed citations
7.
Yee, Judy, Stefanie Weinstein, Benjamin M. Yeh, et al.. (2016). Multiple arterial phase MRI of arterial hypervascular hepatic lesions: improved arterial phase capture and lesion enhancement. Abdominal Radiology. 42(3). 870–876. 24 indexed citations
8.
Fraenkel, Liana, Joseph K. Lim, Guadalupe García–Tsao, et al.. (2015). Variation in Treatment Priorities for Chronic Hepatitis C: A Latent Class Analysis. Patient. 9(3). 241–249. 8 indexed citations
9.
Ho, Edith Y., Hui Shen, Robert Lerrigo, et al.. (2014). Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma. HPB. 16(8). 758–767. 21 indexed citations
10.
Yee, Helen S., Sue Currie, Kathryn Tortorice, et al.. (2011). Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study. Digestive Diseases and Sciences. 56(8). 2439–2448. 5 indexed citations
11.
Vermehren, Johannes, Ming‐Lung Yu, Alexander Monto, et al.. (2011). Multi-center evaluation of the Abbott RealTime HCV Assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C. Journal of Clinical Virology. 52(2). 133–137. 79 indexed citations
12.
Bacchetti, Peter, Ross Boylan, Norah A. Terrault, Alexander Monto, & Marina Berenguer. (2010). Non-Markov Multistate Modeling Using Time-Varying Covariates, with Application to Progression of Liver Fibrosis due to Hepatitis C Following Liver Transplant. The International Journal of Biostatistics. 6(1). Article 7–Article 7. 22 indexed citations
13.
Kardos, Keith, Eugene R. Schiff, Karam Mounzer, et al.. (2010). Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid. Journal of Virological Methods. 172(1-2). 27–31. 87 indexed citations
14.
Sewell, Justin L., et al.. (2009). Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy. European Journal of Gastroenterology & Hepatology. 21(2). 225–229. 13 indexed citations
15.
Chang, Tammy T., Rajiv Sawhney, Alexander Monto, et al.. (2008). Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival. HPB. 10(6). 405–411. 79 indexed citations
16.
Monto, Alexander, Sue Currie, & Teresa L. Wright. (2008). Liver Disease in Injection Drug Users with Hepatitis C, With and Without HIV Coinfection. Journal of Addictive Diseases. 27(2). 49–59. 12 indexed citations
17.
Monto, Alexander, Lorna Dove, Alan Bostrom, et al.. (2005). Hepatic steatosis in HIV/hepatitis C coinfection. Hepatology. 42(2). 310–316. 53 indexed citations
18.
Monto, Alexander, Keyur Patel, Alan Bostrom, et al.. (2004). Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology. 39(3). 826–834. 126 indexed citations
19.
Monto, Alexander, et al.. (2002). Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology. 36(3). 729–736. 296 indexed citations
20.
Monto, Alexander, et al.. (1975). A Survey of Hospital Services for Suicidal Persons. Suicide and Life-Threatening Behavior. 5(3). 169–176. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Cheng Breakdown of academic impact, for papers by Wolf Peter Hofmann Breakdown of academic impact, for papers by Fabio Conti Breakdown of academic impact, for papers by Chung‐Feng Huang Breakdown of academic impact, for papers by Rune Wejstål Breakdown of academic impact, for papers by Zoe Mariñó Breakdown of academic impact, for papers by J. Moussalli Breakdown of academic impact, for papers by Vijayaprakash Suppiah Breakdown of academic impact, for papers by Thomas Lang Breakdown of academic impact, for papers by Ching‐Sheng Hsu
Rankless by CCL
2026